Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hamilton

Showing results (891-900 of 971) with videos related to

Pageof 98
Sort By:
Blood Advances|March 19, 2026
Early Steroid and Anakinra Use to Manage Axicabtagene Ciloleucel Toxicity Reduces the Total Duration of CRS and ICANSWilliam Lee Wang, Dasom Lee, Edna Cheung, et al.
Molecular Psychiatry|December 30, 2009
Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studiesS I Shyn, J Shi, J B Kraft, et al.
Blood Cancer Journal|July 2, 2026
Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphomaKaran L Chohan, Eduardo Edelman Saul, R Eric Davis, et al.
The Plant Cell|March 8, 2021
Eleven biosynthetic genes explain the majority of natural variation in carotenoid levels in maize grainChristine H Diepenbrock, Daniel C Ilut, Maria Magallanes-Lundback, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2021
Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II StudyKathleen N Moore, Setsuko K Chambers, Erika P Hamilton, et al.
Archives of Internal Medicine|January 30, 2008
Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Jackson T Wright, Sonja Harris-Haywood, Sara Pressel, et al.
Oncogene|May 3, 2019
Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancerClaire E Fletcher, Eric Sulpice, Stephanie Combe, et al.
Plos One|September 2, 2021
Examining sex differences in neurodevelopmental and psychiatric genetic risk in anxiety and depressionJoanna Martin, Kimiya Asjadi, Leon Hubbard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
Overall survival with abemaciclib in early breast cancerS Johnston, M Martin, J O'Shaughnessy, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 13, 2012
Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialWilliam C Cushman, Barry R Davis, Sara L Pressel, et al.
Pageof 98

Showing results (891-900 of 971) with videos related to

Sort By:
Pageof 98
Blood Advances|March 19, 2026
Early Steroid and Anakinra Use to Manage Axicabtagene Ciloleucel Toxicity Reduces the Total Duration of CRS and ICANSWilliam Lee Wang, Dasom Lee, Edna Cheung, et al.
Molecular Psychiatry|December 30, 2009
Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studiesS I Shyn, J Shi, J B Kraft, et al.
Blood Cancer Journal|July 2, 2026
Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphomaKaran L Chohan, Eduardo Edelman Saul, R Eric Davis, et al.
The Plant Cell|March 8, 2021
Eleven biosynthetic genes explain the majority of natural variation in carotenoid levels in maize grainChristine H Diepenbrock, Daniel C Ilut, Maria Magallanes-Lundback, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2021
Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II StudyKathleen N Moore, Setsuko K Chambers, Erika P Hamilton, et al.
Archives of Internal Medicine|January 30, 2008
Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Jackson T Wright, Sonja Harris-Haywood, Sara Pressel, et al.
Oncogene|May 3, 2019
Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancerClaire E Fletcher, Eric Sulpice, Stephanie Combe, et al.
Plos One|September 2, 2021
Examining sex differences in neurodevelopmental and psychiatric genetic risk in anxiety and depressionJoanna Martin, Kimiya Asjadi, Leon Hubbard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
Overall survival with abemaciclib in early breast cancerS Johnston, M Martin, J O'Shaughnessy, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 13, 2012
Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialWilliam C Cushman, Barry R Davis, Sara L Pressel, et al.
Pageof 98